Scientists test new Drug's safety in people with liver issues
NCT ID NCT06957756
Summary
This study aims to understand how different levels of liver problems affect how the body processes a new medicine called BI 1584862. It involves adults with mild, moderate, or severe liver impairment, as well as healthy matched participants for comparison. Each participant receives a single dose of the medicine, and researchers closely monitor their health and take blood samples over about five weeks to see how the drug behaves.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Research Corporation
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Arizona Clinical Trials - Chandler
RECRUITINGChandler, Arizona, 85225, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Omega Research Orlando, LLC
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.